|
Q4 2020
Filed on Feb 11, 2021
|
72,010
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
15,415
|
N/A
|
|
Nuveen High Income 2020 Targ
|
Q4 2020
Filed on Feb 11, 2021
|
59,602
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
12,205
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
6,894
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
15,000
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
214,060
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
275,162
|
N/A
|
|
Washington Prime Group New
|
Q4 2020
Filed on Feb 11, 2021
|
25,799
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
10,998
|
$9.28 - $17.12
$102K - $188K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
17,810
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
10,333
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
83,031
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
16,147
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
11,252
|
$21.93 - $27.76
$247K - $312K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
12,135
|
$17.44 - $26.19
$212K - $318K
|
|
Invesco Exch Trd Slf Idx Fd
|
Q4 2020
Filed on Feb 11, 2021
|
588,822
|
N/A
|
|
Invesco Exch Trd Slf Idx Fd
|
Q4 2020
Filed on Feb 11, 2021
|
135,167
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
14,572
|
N/A
|
|
Nuveen Tax Advantaged Divid
|
Q4 2020
Filed on Feb 11, 2021
|
10,423
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
3,504
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
78,474
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
10,126
|
$17.99 - $24.63
$182K - $249K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
10,400
|
$7.82 - $9.02
$81.3K - $93.8K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
12,105
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
18,400
|
$2.28 - $6.84
$42K - $126K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
15,270
|
$55.93 - $82.78
$854K - $1.26M
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
46,500
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
16,013
|
$1.99 - $3.25
$31.9K - $52K
|
|
Oaktree Strategic Income Cor
|
Q4 2020
Filed on Feb 11, 2021
|
10,350
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
11,206
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
147,521
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
18,484
|
$39.2 - $45.68
$725K - $844K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
20,500
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
21,525
|
$3.38 - $4.3
$72.8K - $92.6K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
40,196
|
$0.63 - $1.51
$25.3K - $60.7K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
20,429
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
13,306
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
5,619
|
$46.13 - $57.62
$259K - $324K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
27,105
|
$5.93 - $11.46
$161K - $311K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
26,233
|
N/A
|
|
Proteostasis Therapeutics In
|
Q4 2020
Filed on Feb 11, 2021
|
19,847
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
16,417
|
$6.43 - $10.5
$106K - $172K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
10,850
|
$1.5 - $2.02
$16.3K - $21.9K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
12,177
|
$32.82 - $34.97
$400K - $426K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
18,000
|
$0.2 - $0.4
$3.6K - $7.2K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
22,592
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
13,750
|
N/A
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
4,099
|
$51.38 - $52.31
$211K - $214K
|
|
|
Q4 2020
Filed on Feb 11, 2021
|
9,785
|
$20.37 - $25.01
$199K - $245K
|
|